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Case 4 This patient became ill three weeks after the evacuation of a mole with ovarian cysts enlarging rapidly to above the level of the umbilicus and a rising HCG level. The angiogram ( Fig 6) shows arteriovenous shunting, which is thought to be pathognomonic of chorion carcinoma; it completes the spectrum shown in the previous cases. She was treated on the basis of the total picture and made a satisfactory recovery.
The value of serial angiograms and quantitative gonadotrophin estimations is mainly in the conservative management of borderline cases of trophoblastic disease; we must also use these new diagnostic tools in the study of the natural history of the condition. 
Clinical Presentation and Diagnosis
In 41 cases the pulmonary disease was preceded by hydatidiform mole and in 14 by non-molar pregnancy. In half a primary uterine growth was absent. In a minority the pulmonary lesion was discovered at the same time as the causal pregnancy but more often there was a latent interval, varying from weeks to years.
The chief symptoms of the disease were cough, hmmoptysis, dyspncea and chest pain. Frequently symptoms were absent until the disease was well advanced. The hemagglutination-inhibition test for chorionic gonadotrophin (Wide & Gemzell 1960) and chest radiography were of great help in diagnosis.
Radiographic Appearances
Chest radiography in pulmonary chorion carcinoma gave the following appearances: (1) 'Normal'; small, early lesions were not demonstrable.
(2) 'Heavy vascular markings' -usually associated with mild cardiac enlargement, the results of tumour embolization and pulmonary hypertension.
(3) 'Diffuse mottlings' due to multiple miliary emboli causing foci of hiemorrhage. (4) 'Multiple nodular opacities', denoting a more advanced form of disease. (5) 
The HealedLesion
In cases responding well to chemotherapy the pulmonary lesions disappeared completely but, in a few, radiographic opacities persisted. Three such radiopaque lesions were surgically removed: histology showed extensive fibrosis of the pulmonary nodule with a thick circumferential fibrous 'pseudocapsule' surrounded by islands of lymphocytes. No tumour cells were seen.
Treatment
Prophylactic: The use of prophylactic hysterectomy in the treatment of hydatidiform mole in certain 'risk groups' has been shown to be effective in preventing malignant seuqele, pulmonary disease and death (Tow 1966). The two risk groups are women aged 40 or more and those below 40 who have had three or more children. This policy of prophylactic or primary hysterectomy has been followed, in treating hydatidiform mole, since November 1961. In a series of 31 cases of pulmonary chorion carcinoma following hydatidiform mole there were 12 deaths, all in patients who did not have primary hysterectomy. Therapeutic: The therapeutic measures used were surgery and chemotherapy. The choice of surgery, i.e. hysterectomy, was determined by the extent of the disease and the need for further childbearing. If the pulmonary disease was already extensive or if further childbearing was an important consideration then hysterectomy was not performed.
On the other hand, if the disease was mainly confined to the uterus and if future childbearing was not needed, then hysterectomy was undertaken. Chemotherapy was used in 44 cases. In 11 cases chemotherapy was either not available or was refused. The standard course was methotrexate 20 mg and 6-mercaptopurine 400 mg daily for five to seven days. Therapy was not begun unless the patient was fit, i.e. general condition satisfactory, hemoglobin concentration not less than 12 g % and leucocyte count at least 4,000/c.mm. As a rule, two weeks were allowed between courses for recovery from toxic side-effects. Cases going for surgery received one course of preoperative chemotherapy. Response was checked by periodic estimations of gonadotrophin and chest radiography. Three courses of chemotherapy were given after a negative titre had been obtained, in order to ensure complete eradication of trophoblasts which might perhaps be in a dormant state.
Results
Of the 55 patients, 30 have died, giving an overall survival rate of 45 %. Table 1 shows the results related to the methods of treatment. Chemotherapy has increased the chances of survival from zero to nearly 60%. Prophylactic hysterectomy in the treatment of hydatidiform mole in 'risk groups' gave 100% survival. Hysterectomy did not improve the survival rate in pulmonary It is unusual to find evidence of trophoblast surviving after term delivery or early termination of normal pregnancy. By contrast, trophoblast commonly survives after evacuation of hydatidiform mole. Its location in the uterus, pelvic vasculature or lungs may not be definable but its presence is indicated by continued production of chorionic gonadotrophin. This persisting trophoblast usually dies out spontaneously but Delfs (1959) using bioassays found that it was still present in more than 20% of 118 cases sixty days post-evacuation. The radioimmunossay for HCG-LH (Bagshawe et al. 1966) would possibly give a higher figure because it is more sensitive. After sixty days, spontaneous trophoblastic necrosis may still occur in some
